#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liver abscess Peritoneal neoplasm Propionic acidaemia Soft tissue necrosis Albright's disease IPEX syndrome Von Hippel-Lindau disease Wiskott-Aldrich syndrome Pleural mesothelioma malignant Extra-osseous Ewing's sarcoma metastatic Paraganglion neoplasm Ependymoma Sjogren's syndrome Fatty acid oxidation disorder Brain stem glioma More trials…

    Learn about Rare Diseases

    Mastocytosis – Trials in Disease Progressive multifocal leukoencephalopathy – Life with Disease Hereditary neuropathic amyloidosis Mantle cell lymphoma stage IV – Treatment CADASIL – Basic Information Hereditary ataxia – Basic Information Osteosarcoma – Life with Disease Lymphangiosarcoma Malignant fibrous histiocytoma – Life with Disease Glomerulonephritis membranoproliferative – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VANADIUM OXIDE SULFATE Ibuprofen Lysine Ivonescimab Indacaterol Maleate Ixekizumab Fluconazole Rbl005.3 Repagermanium Msv/As Tropicamide ULTEVURSEN Dazostinag Sapropterin Dihydrochloride Human Normal Immunoglobulin Ivabradine Hydrochloride Blood And Related Products Cloxacillin Sodium Cpk850 Magnesium Chloride Tecaginlimab More therapies…

    Learn about Your Condition

    Eosinophilic gastritis Micrographic skin surgery Polymyositis Neoplasm Contusion Bladder cancer stage II Diphtheria Sinus rhythm Urinary tract infection Colorectal cancer Mantle cell lymphoma stage II Incontinence Hepatic cancer Infective uveitis Coronary artery occlusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Sanitaria Universitaria Giuliano Isontina

Azienda Sanitaria Universitaria Giuliano Isontina

Strada Di Fiume 447, Trieste, 34149, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of levofloxacin, ketorolac trometamol, and dexamethasone eye drops for preventing inflammation and infection after cataract surgery in adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cataract
    Investigated Drugs:
    • KETOROLAC TROMETAMOL
    • Levofloxacin Hemihydrate
    • Levofloxacin
    Greece Italy Poland Spain Sweden

  • Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

    Recruiting

    3 1
    Investigated Diseases:
    • Asthma
    Belgium Estonia France Ireland Italy Slovakia +1

  • Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin Hydrochloride
    • Azacitidine
    • Cytarabine
    Belgium Czechia France Germany Greece Hungary +4

  • A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis

    Recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • GSK3862995B
    Denmark France Germany Italy Poland Spain

  • A study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy

    Recruiting

    3 1
    Investigated Drugs:
    • Empasiprubart
    Austria Bulgaria Czechia Denmark Estonia Finland +9

  • A Study of Danicamtiv for Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy to Test if it Improves Heart Function and Exercise Ability

    Recruiting

    4 1
    Investigated Drugs:
    • Danicamtiv
    Belgium Denmark France Hungary Italy The Netherlands +3

  • A Study of Zanubrutinib for Patients with Anti-MAG Antibody Neuropathy Associated with Blood Disorders or Abnormal Protein in the Blood

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Marginal zone lymphoma
    • Waldenstrom’s macroglobulinaemia
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Zanubrutinib
    Italy

  • A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness

    Recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Bulgaria Croatia Czechia France Germany Greece +6

  • Testing Bisoprolol in Patients with Acute or Recurrent Pericarditis to Reduce Symptoms and Prevent Recurrence

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypotension
    Investigated Drugs:
    • Bisoprolol
    Italy

  • A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

    Recruiting

    3 1
    Bulgaria Croatia Czechia France Germany Greece +6
1 2 3 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!